Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT‐2, MIRACLE‐ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL
Open Access
- 1 June 2002
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 4 (3), 381-388
- https://doi.org/10.1016/s1388-9842(02)00040-5
Abstract
This article continues a series of reports updating recent research developments of particular interest to personnel involved in the treatment and management of patients with heart failure. This is a summary of selected presentations made at the American College of Cardiology 51st Annual Scientific Session held in Atlanta on 17–20 March 2002. Reports of the following clinical studies are included: LIFE, DANAMI 2, MADIT‐2, MIRACLE‐ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL.Keywords
This publication has 14 references indexed in Scilit:
- Expanding Indications for Implantable Cardiac DefibrillatorsNew England Journal of Medicine, 2002
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- Why ICD patients with heart failure (Class II–IV) are hospitalized: do the reasons differ for patients who are treated with cardiac resynchronization therapy?Journal of the American College of Cardiology, 2002
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%Journal of the American College of Cardiology, 2002
- Systematic review of the management of atrial fibrillation in patients with heart failureEuropean Heart Journal, 2000
- Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart FailureCirculation, 1999
- The Carvedilol Hibernation Reversible Ischaemia Trial; Marker of Success (CHRISTMAS)European Journal of Heart Failure, 1999
- Risk stratification in chronic heart failurePublished by Oxford University Press (OUP) ,1998